Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical, Inc.    ISRG

INTUITIVE SURGICAL, INC.

(ISRG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 2 704 3 129 3 724 4 465 4 655 5 452
EBITDA 1 227 1 154 1 660 1 851 1 843 2 195
Operating profit (EBIT) 945 1 055 1 537 1 738 1 720 2 073
Pre-Tax Profit (EBT) 981 1 097 1 280 1 500 1 493 1 867
Net income 736 660 1 128 1 344 1 195 1 487
P/E ratio 33,9x 64,4x 50,5x 42,9x 43,8x 36,4x
EPS ( $ ) 6,24 5,67 9,49 10,9 10,7 12,9
Dividend per Share ( $ ) - - - - - -
Yield - - - - - -
Reference price ( $ ) 211,390 364,940 478,920 467,720 467,720 467,720
Announcement Date 01/24/2017
09:05pm
01/25/2018
09:05pm
01/24/2019
09:05pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - - -
Finance 1 037 1 634 2 725 1 762 3 101 4 212
Operating income (EBITDA) 1 227 1 154 1 660 1 851 1 843 2 195
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 53,9 191 187 337 289 322
Free Cash Flow (FCF) 989 953 982 1 153 1 301 1 540
Book Value Per Share (BVPS) ( $ ) 50,3 40,6 56,2 69,4 73,7 84,5
Cash Flow per Share ( $ ) 8,85 9,84 9,85 13,2 14,9 20,6
Announcement Date 01/24/2017
09:05pm
01/25/2018
09:05pm
01/24/2019
09:05pm
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 54 606 M $ -
Entreprise Value (EV) 52 844 M $ 51 506 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 42,9x 43,8x
Capitalization / Revenue 12,2x 11,7x
EV / Revenue 11,8x 11,4x
EV / EBITDA 28,6x 28,7x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 6,74x 6,34x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 38,9% 37,0%
Operating Leverage (Delta EBIT / Delta Sales) 0,66x -
Net Margin (Net Profit / Revenue) 30,1% 25,7%
ROA (Net Profit / Asset) 16,2% 13,7%
ROE (Net Profit / Equities) 19,4% 16,2%
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   7,55% 6,20%
Cash Flow / Sales 34,4% 37,3%
Capital Intensity (Assets / Sales) 1,85x 1,87x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend